Large-scale testing (Phase 3)Looking for participantsNCT06003387
What this trial is testing
Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)
Who this might be right for
Hemophilia B
CSL Behring 35